Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Neurobiol Dis. 2013 Feb;50:151-9. doi: 10.1016/j.nbd.2012.09.005. Epub 2012 Sep 23.
Several episodic neurological disorders are caused by ion channel gene mutations. In patients, transient neurological dysfunction is often evoked by stress, caffeine and ethanol, but the mechanisms underlying these triggers are unclear because each has diverse and diffuse effects on the CNS. Attacks of motor dysfunction in the Ca(V)2.1 calcium channel mouse mutant tottering are also triggered by stress, caffeine and ethanol. Therefore, we used the tottering mouse attacks to explore the pathomechanisms of the triggers. Despite the diffuse physiological effects of these triggers, ryanodine receptor blockers prevented attacks induced by all of them. In contrast, compounds that potentiate ryanodine receptors triggered attacks suggesting a convergent biochemical pathway. Tottering mouse attacks were both induced and blocked within the cerebellum suggesting that the triggers act locally to instigate attacks. In fact, stress, caffeine and alcohol precipitated attacks in Ca(V)2.1 mutant mice in which genetic pathology was limited to cerebellar Purkinje cells, suggesting that the triggers initiate dysfunction within a specific brain region. The surprising biochemical and anatomical specificity of the triggers and the discovery that the triggers operate through shared mechanisms suggest that it is possible to develop targeted therapies aimed at blocking the induction of episodic neurological dysfunction, rather than treating the symptoms once provoked.
几种间歇性神经系统疾病是由离子通道基因突变引起的。在患者中,短暂的神经功能障碍通常由应激、咖啡因和乙醇诱发,但这些诱因的机制尚不清楚,因为它们对中枢神经系统有不同和广泛的影响。钙通道小鼠突变体 tottering 的运动功能障碍发作也受应激、咖啡因和乙醇的触发。因此,我们使用 tottering 小鼠发作来探索诱因的病理机制。尽管这些诱因具有广泛的生理作用,但 Ryanodine 受体阻滞剂可预防所有诱因引起的发作。相比之下,增强 Ryanodine 受体的化合物会引发发作,表明存在一个集中的生化途径。 tottering 小鼠的发作既可以在小脑内诱导,也可以在小脑内阻断,这表明这些诱因在局部作用以引发发作。事实上,应激、咖啡因和酒精会引发仅在小脑浦肯野细胞中存在遗传病理学的 Ca(V)2.1 突变小鼠的发作,这表明这些诱因会引发特定脑区的功能障碍。诱因的惊人生化和解剖特异性,以及发现这些诱因通过共享机制起作用,表明有可能开发靶向治疗方法,旨在阻止间歇性神经功能障碍的诱导,而不是在发作后治疗症状。